|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/24 |
| (11) | Number of the document | 2064246 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08714214.7 |
| Date of filing the European patent application | 2008-02-08 | |
| (97) | Date of publication of the European application | 2009-06-03 |
| (45) | Date of publication and mention of the grant of the patent | 2013-05-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/001717 |
| Date | 2008-02-08 |
| (87) | Number | WO 2008/153610 |
| Date | 2008-12-18 |
| (30) | Number | Date | Country code |
| 889475 P | 2007-02-12 | US |
| (72) |
KOPF, Manfred, CH
ROMANI, Luigina, IT
KASTELEIN, Robert, A., US
CHACKERIAN, Alissa, A., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION |
| USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION |